PLIANT THERAPEUTICS INC's ticker is PLRX and the CUSIP is 729139105. A total of 93 filers reported holding PLIANT THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,584,033 | -4.6% | 379,702 | -0.3% | 2.37% | -3.2% |
| Q2 2023 | $6,898,773 | -17.2% | 380,727 | +21.5% | 2.45% | -23.5% |
| Q1 2023 | $8,332,397 | +41.5% | 313,248 | +2.8% | 3.20% | +31.3% |
| Q4 2022 | $5,887,396 | +26.5% | 304,573 | +36.7% | 2.44% | +24.1% |
| Q3 2022 | $4,653,000 | +173.7% | 222,757 | +5.0% | 1.96% | +167.7% |
| Q2 2022 | $1,700,000 | -3.3% | 212,210 | +14.0% | 0.73% | +18.8% |
| Q1 2022 | $1,758,000 | -25.3% | 186,110 | +6.8% | 0.62% | -19.9% |
| Q4 2021 | $2,353,000 | -16.3% | 174,260 | +4.7% | 0.77% | -20.2% |
| Q3 2021 | $2,810,000 | -36.3% | 166,447 | +10.1% | 0.96% | -33.9% |
| Q2 2021 | $4,410,000 | – | 151,111 | – | 1.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 339,160 | $5,881,034 | 100.00% |
| CHI Advisors LLC | 3,014,199 | $52,266,211 | 20.72% |
| TRV GP IV, LLC | 2,132,867 | $36,983,914 | 13.93% |
| GREAT POINT PARTNERS LLC | 1,755,184 | $30,434,891 | 5.54% |
| First Light Asset Management, LLC | 2,933,260 | $50,862,728 | 4.83% |
| Deep Track Capital, LP | 5,500,000 | $95,370,000 | 3.68% |
| Casdin Capital, LLC | 1,577,108 | $27,347,053 | 3.03% |
| Fernwood Investment Management, LLC | 379,702 | $6,584,033 | 2.37% |
| Redmile Group, LLC | 2,678,099 | $46,438,237 | 2.21% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 250,409 | $4,342,092 | 1.32% |